Expression of the Immune Checkpoint LAG-3 and its Ligand Gal-3 in High-Grade Serous Ovarian Carcinoma

被引：0
|
作者：
Whitehair, Rachel [1 ]
Peres, Lauren [2 ]
Mills, Anne [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
LABORATORY INVESTIGATION | 2019年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1144
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Expression of the Immune Checkpoint LAG-3 and its Ligand Gal-3 in High-Grade Serous Ovarian Carcinoma
    Whitehair, Rachel
    Peres, Lauren
    Mills, Anne
    MODERN PATHOLOGY, 2019, 32
  • [2] The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous Neoplasia
    Cocks, Margaret M.
    Mills, Anne M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2022, 41 (02) : 113 - 121
  • [3] LAG-3 and GAL-3 in Endometrial Carcinoma: Emerging Candidates for Immunotherapy
    Friedman, Lisa A.
    Ring, Kari L.
    Mills, Anne M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (03) : 203 - 212
  • [4] Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and GermlineBRCAStatus
    Whitehair, Rachel
    Peres, Lauren C.
    Mills, Anne M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2020, 39 (06) : 558 - 566
  • [5] PD-L1, LAG-3, and GAL-3 Expression in Anal Squamous Cell Carcinoma
    Ju, Jennifer
    Mills, Anne
    Stelow, Edward
    MODERN PATHOLOGY, 2019, 32
  • [6] PD-L1, LAG-3, and GAL-3 Expression in Anal Squamous Cell Carcinoma
    Ju, Jennifer
    Mills, Anne
    Stelow, Edward
    LABORATORY INVESTIGATION, 2019, 99
  • [7] Differential expression of immune related genes in high-grade ovarian serous carcinoma
    Siamakpour-Reihani, Sharareh
    Cobb, Lauren Patterson
    Jiang, Chen
    Zhang, Dadong
    Previs, Rebecca A.
    Owzar, Kouros
    Nixon, Andrew B.
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2020, 156 (03) : 662 - 668
  • [8] LAG-3 and GAL-3: Emerging Avenues for Immunotherapy in Mismatch Repair-Deficient Endometrial Carcinoma
    Friedman, Lisa
    Ring, Kari
    Mills, Anne
    MODERN PATHOLOGY, 2019, 32
  • [9] LAG-3 and GAL-3: Emerging Avenues for Immunotherapy in Mismatch Repair-Deficient Endometrial Carcinoma
    Friedman, Lisa
    Ring, Kari
    Mills, Anne
    LABORATORY INVESTIGATION, 2019, 99
  • [10] Serum LAG-3 is associated with improved patient prognosis in high grade serous ovarian cancer
    Eurich, Katrin
    James, Nicole
    Lips, Erin
    De La Cruz, Payton
    Woodman, Morgan
    Ribeiro, Jennifer
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S114 - S114
12345